[go: up one dir, main page]

WO2006060774A3 - Inhibiteurs de la replication de flavivirus et leurs utilisations - Google Patents

Inhibiteurs de la replication de flavivirus et leurs utilisations Download PDF

Info

Publication number
WO2006060774A3
WO2006060774A3 PCT/US2005/043938 US2005043938W WO2006060774A3 WO 2006060774 A3 WO2006060774 A3 WO 2006060774A3 US 2005043938 W US2005043938 W US 2005043938W WO 2006060774 A3 WO2006060774 A3 WO 2006060774A3
Authority
WO
WIPO (PCT)
Prior art keywords
agents
flavivirus replication
inhibit flavivirus
inhibit
replication
Prior art date
Application number
PCT/US2005/043938
Other languages
English (en)
Other versions
WO2006060774A2 (fr
Inventor
Scott R Gilbertson
Pedro J Lory
Robert D Malmstrom
Yuan-Ping Pang
Andrew T Russo
Stanley J Watowich
Original Assignee
Univ Texas
Mayo Foundation
Scott R Gilbertson
Pedro J Lory
Robert D Malmstrom
Yuan-Ping Pang
Andrew T Russo
Stanley J Watowich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Mayo Foundation, Scott R Gilbertson, Pedro J Lory, Robert D Malmstrom, Yuan-Ping Pang, Andrew T Russo, Stanley J Watowich filed Critical Univ Texas
Publication of WO2006060774A2 publication Critical patent/WO2006060774A2/fr
Publication of WO2006060774A3 publication Critical patent/WO2006060774A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12—Thioxanthenes
    • C07D335/14—Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D335/16—Oxygen atoms, e.g. thioxanthones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention a trait à des composés présentant une activité contre une variété de flavivirus, à leurs utilisations, et à des procédés pour l'identification de tels composés.
PCT/US2005/043938 2004-12-02 2005-12-02 Inhibiteurs de la replication de flavivirus et leurs utilisations WO2006060774A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63274904P 2004-12-02 2004-12-02
US60/632,749 2004-12-02

Publications (2)

Publication Number Publication Date
WO2006060774A2 WO2006060774A2 (fr) 2006-06-08
WO2006060774A3 true WO2006060774A3 (fr) 2007-03-22

Family

ID=36565839

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/043938 WO2006060774A2 (fr) 2004-12-02 2005-12-02 Inhibiteurs de la replication de flavivirus et leurs utilisations

Country Status (1)

Country Link
WO (1) WO2006060774A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7480400B2 (en) 2006-03-16 2009-01-20 Siemens Medical Solutions Usa, Inc. Detection of fiber pathways
GB2443892B (en) * 2007-01-13 2010-11-24 Shahnaz Perveen "Gaschem " a urease and alpha-chymotrypsin enzyme inhibito ry drug
PL2308514T3 (pl) 2007-03-23 2013-11-29 To Bbb Holding B V Koniugaty do ukierunkowanego dostarczania leku poprzez barierę krew-mózg
JP6091636B2 (ja) * 2012-11-08 2017-03-08 中国科学院理化技術研究所 チオキサントンオキシド系誘導物、製造方法及びその応用
CN113429238A (zh) * 2021-07-23 2021-09-24 甘肃省农业科学院旱地农业研究所 一种有机肥及其制备方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] COATES ET AL.: "New Therapeutic agents of the quinoline series. Introduction and II. Methoxy-, hydroxy-, and alkylpyridylquinolines", XP003009984, Database accession no. (1944:520) *
DATABASE CAPLUS [online] COOK A.H. ET AL.: "New Therapeutic agents of the quinoline series, Introduction and IV. Lutidylquinolines", XP003009983, Database accession no. (1944:521) *
J. CHEM. SOCIETY, 1943, pages 406 - 413 *
J. CHEM. SOCIETY, 1943, pages 413 - 417 *

Also Published As

Publication number Publication date
WO2006060774A2 (fr) 2006-06-08

Similar Documents

Publication Publication Date Title
WO2006120176A3 (fr) Combinaison d'un inhibiteur de pde4 et un derive de tetrahydrobiopterine
WO2006056399A3 (fr) Combinaisons d'inhibiteurs de kinase jak
WO2008127226A3 (fr) Antagonistes de kinase p13
WO2006091529A3 (fr) Preparation pharmaceutique solide
WO2007019439A3 (fr) Compositions de copolymere sequence et utilisations de ces dernieres
WO2005118511A3 (fr) Composes, compositions et methodes permettant de stabiliser la transthyretine et d'inhiber un mauvais repliement de la transthyretine
IL182061A0 (en) Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus
WO2006071762A3 (fr) Inhibiteurs de dipeptidyl-peptidase iv a base de pyrimidine et methodes associees
IL180872A0 (en) Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
WO2007133290A8 (fr) Anticorps anti-ox40l et méthodes correspondantes
IL182765A0 (en) Pyridazine compounds, compositions and methods
SG159547A1 (en) Methods and compositions for modulating hyperstabilized c-met
CA115126S (en) Ink cartridge
WO2004101742A3 (fr) Inhibiteurs de protease pour les coronavirus et le sars-cov et leur utilisation
WO2007106436A3 (fr) Composes et compositions photoactifs et utilisations derivees
CA115127S (en) Ink cartridge
WO2007056625A3 (fr) Inhibiteurs de thienopyridine b-raf kinase
IL180879A0 (en) Methods and compositions for inhibiting, destroying, and/or inactivating viruses
WO2007076159A3 (fr) Bromhydrate de darifenacine pur sensiblement exempt de darifenacine oxydee, sels de celui-ci, et procedes de preparation de ceux-ci
CA115124S (en) Ink cartridge
WO2007095258A3 (fr) compositions comprenant un rhamnolipide et leurs procedes d'utilisation
WO2005082020A8 (fr) Vaccin du flavivirus
WO2008048121A3 (fr) Composés et compositions
WO2006023603A3 (fr) Compositions d'inhibiteur pde5 et méthodes de traitement des troubles cardiaques
WO2006098998A3 (fr) Procedes et compositions de modulation de l'integrite vasculaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05852989

Country of ref document: EP

Kind code of ref document: A2